{"text": ["Do", "AbbVie's", "(NYSE:ABBV)", "Earnings", "Warrant", "Your", "Attention?"], "created_at": "2020-08-25 18:42:29"}
{"text": ["AbbVie", "Submits", "Regulatory", "Application", "to", "FDA", "for", "RINVOQ\u2122", "(upadacitinib)", "for", "the", "Treatment", "of", "Adults", "with", "Active", "Ankylosing", "Spondylitis"], "created_at": "2020-08-25 12:45:00"}
{"text": ["The", "Daily", "Biotech", "Pulse:", "Altimmune", "Reports", "Positive", "Preclinical", "Data", "For", "Intranasal", "COVID-19", "Vaccine,", "AbbVie", "Licenses", "Morphic's", "Drug,", "Viveve", "Clinical", "Readout"], "created_at": "2020-08-25 12:38:16"}
{"text": ["AbbVie,", "Harvard", "University", "Form", "Research", "Alliance", "to", "Address", "Emergent", "Viral", "Diseases"], "created_at": "2020-08-25 12:00:00"}
{"text": ["Morphic", "Announces", "that", "AbbVie", "Exercises", "License", "Option", "to", "\u03b1v\u03b26", "Integrin", "Inhibitor", "Program,", "Including", "MORF-720,", "for", "Fibrotic", "Diseases"], "created_at": "2020-08-25 10:30:00"}
